NCT03265444View on ClinicalTrials.gov

Safety and Tolerability of CS10BR05 Inj. in Subjects with Multiple System Atrophy

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 13, 2018

Primary Completion Date

December 5, 2019

Study Completion Date

December 5, 2019

Conditions
Multiple System Atrophy
Interventions
BIOLOGICAL

CS10BR05

The single injection of CS10BR05 Inj. in the carotid artery; Step 1 dose : 3.0x105cells/kg; Step 2 dose : 6.0x105cells/kg; Step 3 dose : 9.0x105cells/kg; The duration of follow up study following the single dose of CS10BR05 is 28 days.

Trial Locations (1)

Unknown

Yonsei University College of Medicine, Seoul

Sponsors
All Listed Sponsors
lead

Corestemchemon, Inc.

INDUSTRY

NCT03265444 - Safety and Tolerability of CS10BR05 Inj. in Subjects with Multiple System Atrophy | Biotech Hunter | Biotech Hunter